https://www.genpo.org/ Advancing Genetics & Biology for a Better World en Tue, 14 Jul 2026 00:16:08 GMT https://www.genpo.org/hidden-switches-dna-regulatory-sequences-gene-expression/ https://www.genpo.org/hidden-switches-dna-regulatory-sequences-gene-expression/ Genes that code for proteins represent only a fraction of the genome's functional landscape. Scattered throughout the remaining sequence are regulatory elements—enhancers, silencers, and promoters—that determine when, where, and how intensely any given gene operates. Understanding these molecular control mechanisms is rapidly reshaping the science of disease diagnosis and precision medicine. GenPo Science Genomics & Public Education Tue, 14 Jul 2026 00:15:20 GMT https://www.genpo.org/where-did-the-heritability-go-genetics-missing-heritability-problem/ https://www.genpo.org/where-did-the-heritability-go-genetics-missing-heritability-problem/ Genome-wide association studies promised to reveal the genetic roots of common diseases, yet the variants they uncovered account for only a fraction of what family histories suggest should be heritable. This gap—what researchers call the missing heritability problem—is forcing a fundamental rethinking of how genes, environment, and molecular complexity interact to shape human traits and disease risk. GenPo Science Genomics & Public Education Mon, 13 Jul 2026 19:35:23 GMT https://www.genpo.org/same-genes-different-fates-genetic-risk-not-destiny/ https://www.genpo.org/same-genes-different-fates-genetic-risk-not-destiny/ Carrying a genetic variant associated with heart disease, diabetes, or Alzheimer's does not guarantee that disease will ever materialize. Emerging research into penetrance and phenotypic plasticity is fundamentally reshaping how clinicians and scientists communicate genetic risk to patients. Understanding this distinction may be one of the most consequential shifts in modern medicine. GenPo Science Clinical Genetics Mon, 13 Jul 2026 08:15:12 GMT https://www.genpo.org/methylation-molecular-clocks-biological-aging-epigenetics/ https://www.genpo.org/methylation-molecular-clocks-biological-aging-epigenetics/ Scientists have discovered that chemical tags on your DNA can reveal how old your cells truly are—sometimes diverging dramatically from your birth certificate. This article examines the biology of epigenetic clocks, what the latest research tells us about influencing them, and how to separate genuine scientific progress from the growing chorus of longevity marketing claims. GenPo Science Genomics & Public Education Mon, 13 Jul 2026 04:15:07 GMT https://www.genpo.org/methylation-mortality-molecular-clocks-dna-biological-age/ https://www.genpo.org/methylation-mortality-molecular-clocks-dna-biological-age/ Epigenetic clocks—tools that measure chemical modifications across the genome—are reshaping how scientists define and quantify biological aging. Unlike a birth certificate, these molecular markers reflect how the body has actually weathered time at the cellular level, offering researchers and clinicians a potentially transformative window into longevity and disease risk. GenPo Science Genomics & Public Education Mon, 13 Jul 2026 04:10:12 GMT https://www.genpo.org/epigenome-environmental-factors-gene-expression/ https://www.genpo.org/epigenome-environmental-factors-gene-expression/ Your DNA sequence may be fixed at birth, but a dynamic layer of chemical signals sits above it, continuously reshaping which genes are active and which remain silent. Emerging epigenetic research reveals that diet, chronic stress, physical activity, and even sleep patterns can alter these signals in ways that influence disease risk and longevity. Understanding this molecular conversation between lifestyle and genome is rapidly changing how scientists approach everything from cancer biology to ag GenPo Science Genomics & Public Education Sun, 12 Jul 2026 19:00:18 GMT https://www.genpo.org/crispr-gene-editing-fda-approved-clinical-treatments/ https://www.genpo.org/crispr-gene-editing-fda-approved-clinical-treatments/ Once confined to research laboratories, CRISPR-based therapies have crossed a historic threshold with FDA approvals that are reshaping what is possible for patients with previously untreatable genetic diseases. This milestone marks not just a scientific achievement, but a fundamental shift in how medicine addresses the root causes of inherited conditions. The journey from discovery to clinic, however, carries important questions about access, equity, and the long-term responsibilities of a socie GenPo Science Clinical Genetics Wed, 08 Jul 2026 16:05:36 GMT https://www.genpo.org/understanding-consumer-dna-ancestry-test-results-science/ https://www.genpo.org/understanding-consumer-dna-ancestry-test-results-science/ Millions of Americans have mailed off a saliva sample and waited eagerly for a colorful pie chart declaring them part Irish, part West African, or surprisingly Scandinavian. But the science powering those results is considerably more nuanced — and more uncertain — than the confident percentages on the screen suggest. Understanding how consumer genomic companies construct ancestry estimates, assess disease risk, and report inherited traits can transform you from a passive recipient of data into a GenPo Science Genomics & Public Education Wed, 08 Jul 2026 16:05:36 GMT